Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LifeMD : Teams with a Leading Provider of Diagnostic Services and Axle Health to Deliver Telehealth Access to At-Home Diagnostics

07/15/2021 | 07:31am EDT

NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has teamed with the world’s leading provider of laboratory diagnostic services and Axle Health, a technology leader in in-home healthcare, to deliver telehealth access to diagnostic laboratory testing services.

Patients of LifeMD’s affiliated providers gain access to more than 150 of the most ordered laboratory tests at substantially discounted prices, and which can be completed in the comfort, safety, and convenience of their home or office. This includes urine sample collection and blood draws performed by Axle’s highly trained healthcare professionals, who will ensure secure and timely delivery to local labs. Patients can also visit any of more than 2,200 lab service centers located nationwide.

“Adding laboratory diagnostics services to our LifeMD telehealth platform greatly advances our mission of fundamentally changing the way healthcare is accessed, delivered, and afforded,” noted LifeMD’s chief medical officer, Dr. Anthony Puopolo. “We know that early diagnosis can be critical to creating the best healthcare outcomes. We believe that through our partnership with two of the nation’s leading care providers, we can deliver diagnostics in a way that can better support early diagnosis and thereby have a profound impact on the health and well-being of patients.”

Axle Health’s co-founder and COO, Adam Stansell, commented: “LifeMD shares our forward-thinking approach to healthcare and commitment to providing the best in patient services. This new level of personalized services represents the next evolution of healthcare by bridging the gap between virtual and in-person care. It enables patients to take better care of their health and of their loved ones.”

“This unique technology integration of our respective healthcare platforms will provide our physicians timely and accurate diagnostic information critical to providing the highest quality health care,” said LifeMD CEO, Justin Schreiber. “Direct-to-patient diagnostics will play a major role in making LifeMD the best in virtual primary care, while also supporting the continued expansion of our portfolio of condition-specific telemedicine offerings.“

About Axle Health
Axle Health enables any healthcare company to offer in-home visits to their patients. Axle provides the software platform, operational management, and network of healthcare professionals to handle in-home care, so providers can maintain lasting relationships with their patients over video and chat, while Axle provides physical services in their home. To learn more, visit www.axlehealth.com.

About LifeMD
LifeMD, Inc. is a rapidly growing, direct-to-patient, telehealth company offering virtual medical care across all 50 states. LifeMD’s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient’s home.  To learn more, visit www.LifeMD.com 

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our plans, strategies, and prospects—both business and financial. While we believe that our plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as “believe,” “expect,” “anticipate,” “should,” “planned,” “will,” “may,” “intend,” “estimated,” and “potential,” among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to LifeMD, Inc., or a person acting on its behalf, are expressly qualified in their entirety by this cautionary language.

Company Contact 
LifeMD, Inc.
Marc Benathen, CFO

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC

Primary Logo

Source: LifeMD, Inc.

2021 GlobeNewswire, Inc., source Press Releases

All news about LIFEMD, INC.
08:01aLIFEMD : to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
09/13LIFEMD : Industry veteran brings deep financial and management expertise to LifeMD as comp..
09/13LIFEMD, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
09/13LIFEMD : Appoints Seasoned Investor Naveen Bhatia to Board of Directors
09/13LifeMD, Inc. Appoints Naveen Bhatia to its Board of Directors
09/08LIFEMD : to Present at the H.C. Wainwright Annual Global Investment Conference
08/30LIFEMD : to Adopt Prescryptive Health Digital Pharmacy, Prescriptions Platform for Telehea..
08/30LIFEMD : Partners With Prescryptive Health, Expanding Convenience and Affordability for Pa..
08/30LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for P..
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 97,8 M - -
Net income 2021 -57,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,19x
Yield 2021 -
Capitalization 181 M 181 M -
Capi. / Sales 2021 1,85x
Capi. / Sales 2022 1,25x
Nbr of Employees 56
Free-Float 67,2%
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Last Close Price 6,82 $
Average target price 30,00 $
Spread / Average Target 340%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Independent Director & Chief Medical Officer-US
Stefan Galluppi Director & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.4.44%181
AMAZON.COM, INC.6.31%1 699 478
JD.COM, INC.-15.64%115 092
WAYFAIR INC.24.27%29 155
ETSY, INC.22.34%27 551
ALLEGRO.EU SA-26.36%16 294